<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 5: Cardiovascular Health and Advanced Lipidology | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
}

.takeaways-box li {
 padding-left: 32px;
 position: relative;
 margin-bottom: 12px;
 color: #ffffff;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #B8860B;
 font-weight: 700;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

.references-box ol {
 list-style: none;
 padding: 0;
}

.references-box li {
 padding: 8px 0 8px 36px;
 position: relative;
 font-size: 14px;
 color: #475569;
}

.references-box li::before {
 content: attr(data-num);
 position: absolute;
 left: 0;
 top: 10px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 13: L1 Deep Dive - Advanced Clinical Applications</span>
 <h1 class="lesson-title">Cardiovascular Health and Advanced Lipidology</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üí° Lesson 5 of 8</span>
 <span class="meta-badge">üõ°Ô∏è Level 1 Deep Dive</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Clinical Standard</div>
 <div class="title">AccrediPro Standards Institute Certification</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#lipidology"><span class="section-num">01</span>Beyond LDL: Advanced Lipids</a></li>
 <li><a href="#vascular"><span class="section-num">02</span>Endothelial Dysfunction</a></li>
 <li><a href="#liver-heart"><span class="section-num">03</span>The NAFLD-Cardiac Link</a></li>
 <li><a href="#activity-pillar"><span class="section-num">04</span>Targeting Arterial Stiffness</a></li>
 <li><a href="#raas-monitoring"><span class="section-num">05</span>RAAS in PCOS Subtypes</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> While previous lessons explored the gut-ovary axis and pregnancy, we now shift to the long-term longevity of the PCOS client. Cardiovascular disease (CVD) remains the leading cause of mortality in women with PCOS, making advanced lipidology a cornerstone of the <strong>S.T.E.A.D.Y. Method‚Ñ¢</strong>.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering Vascular Vitality</h3>
 <p>Welcome to one of the most critical lessons for the mid-life PCOS practitioner. As our clients move into their 40s and 50s, the metabolic "noise" of PCOS translates into vascular risk. In this lesson, we move beyond basic cholesterol panels to understand the actual drivers of plaque and arterial aging. You will learn to identify the "hidden" risks that standard medical screenings often overlook.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the clinical significance of ApoB and Lp(a) over standard LDL-C in PCOS metabolic profiling.</li>
 <li>Explain the mechanism by which hyperandrogenism drives endothelial dysfunction and hypertension.</li>
 <li>Evaluate the synergistic risk between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular events.</li>
 <li>Design exercise interventions specifically targeting arterial stiffness and pulse wave velocity.</li>
 <li>Differentiate the cardiovascular monitoring needs for lean vs. adrenal PCOS phenotypes.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë§</div>
 <div>
 <p class="title">Case Study: The "Healthy" High-Risk Client</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">üë©</div>
 <div class="patient-info">
 <h4>Sarah, 48</h4>
 <p>PCOS (Phenotype A), BMI 24.2, Regular Exerciser</p>
 </div>
 </div>
 <p>Sarah came to her practitioner frustrated. Her doctor said her "LDL was fine" at 110 mg/dL, but she had a family history of early heart attacks. Sarah felt "puffy" and noticed her blood pressure creeping up to 135/88 mmHg despite a clean diet.</p>
 <p><strong>Advanced Intervention:</strong> Her specialist ordered an <strong>ApoB</strong> and <strong>Lp(a)</strong> test. While her LDL was moderate, her ApoB was in the 95th percentile, and her Lp(a) was elevated. This revealed a high concentration of small, dense, atherogenic particles that the standard panel missed. By applying the <strong>'A' (Activity)</strong> and <strong>'D' (Detox)</strong> pillars, Sarah's practitioner helped her lower vascular inflammation and stabilize her pressure within 4 months.</p>
 </div>
 </div>

 <h2 id="lipidology">Beyond LDL: Advanced Lipidology in PCOS</h2>
 <p>For decades, the medical community focused almost exclusively on LDL-cholesterol (LDL-C). However, in PCOS, LDL-C is often a <span class="highlight">poor predictor of actual risk</span>. Because PCOS is a state of insulin resistance, the lipid profile typically shifts toward "Pattern B"‚Äîcharacterized by small, dense LDL particles that are more likely to oxidize and penetrate the arterial wall.</p>

 <h3>The Power of ApoB and Lp(a)</h3>
 <p>Apolipoprotein B (ApoB) is a direct measure of the total number of atherogenic particles (LDL, VLDL, and IDL). Since each "bad" particle has exactly one ApoB molecule, this test tells us the <em>particle count</em> rather than just the <em>weight</em> of the cholesterol inside them.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Standard Significance</th>
 <th>PCOS Specific Insight</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>ApoB</strong></td>
 <td>Total atherogenic particle count.</td>
 <td>The most accurate marker for risk when triglycerides are elevated.</td>
 </tr>
 <tr>
 <td><strong>Lp(a)</strong></td>
 <td>Genetic "sticky" cholesterol.</td>
 <td>Often elevated in PCOS; acts as a multiplier for other risks.</td>
 </tr>
 <tr>
 <td><strong>Trig/HDL Ratio</strong></td>
 <td>Insulin resistance proxy.</td>
 <td>A ratio > 2.0 suggests small, dense LDL particles (Pattern B).</td>
 </tr>
 <tr>
 <td><strong>OxLDL</strong></td>
 <td>Oxidized LDL.</td>
 <td>Measures systemic oxidative stress affecting the vascular lining.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>Clients are often told their labs are "normal" because their LDL is under 130. As a specialist, you can provide immense value by suggesting an ApoB test (usually $20-$30). A high ApoB with a "normal" LDL indicates a high number of small, dangerous particles. This is a "lightbulb moment" for clients that justifies more intensive metabolic tuning.</p>
 </div>

 <h2 id="vascular">Endothelial Dysfunction: The Hyperandrogenism Link</h2>
 <p>We often think of high testosterone (hyperandrogenism) as just causing acne or hair growth. However, androgens have a direct, <span class="highlight">deleterious effect on the endothelium</span> (the inner lining of the blood vessels). In women, excess androgens impair the production of <strong>Nitric Oxide (NO)</strong>, the molecule responsible for vasodilation.</p>

 <p>When the endothelium cannot relax, blood pressure rises, and the stage is set for <strong>atherosclerosis</strong>. A 2022 study found that women with PCOS have significantly higher <em>Pulse Wave Velocity (PWV)</em>‚Äîa gold-standard measure of arterial stiffness‚Äîcompared to age-matched controls, even when weight is identical.</p>

 <h3>The RAAS Connection</h3>
 <p>The Renin-Angiotensin-Aldosterone System (RAAS) regulates blood pressure. Hyperinsulinemia (common in PCOS) directly stimulates the kidneys to reabsorb sodium and activates the RAAS. This is why many PCOS clients develop "salt-sensitive" hypertension.</p>

 <div class="coach-tip">
 <span class="tip-label">Income Opportunity</span>
 <p>Many specialists offer "Vascular Vitality Intensives"‚Äîa 90-minute deep dive into advanced lipids and blood pressure mapping. Practitioners like "Maria," a former nurse turned PCOS specialist, charge $497 for these targeted sessions, providing a high-value entry point for clients concerned about longevity.</p>
 </div>

 <h2 id="liver-heart">NAFLD: The Liver-Heart Axis</h2>
 <p>Non-Alcoholic Fatty Liver Disease (NAFLD) is now recognized as the "hepatic manifestation of metabolic syndrome." In PCOS, the prevalence of NAFLD is <span class="highlight">nearly 40-50%</span>, compared to 20% in the general female population. The liver is not just a filter; it is a metabolic furnace.</p>

 <p>When the liver becomes infiltrated with fat, it secretes pro-inflammatory cytokines (IL-6, TNF-alpha) directly into the systemic circulation. These cytokines accelerate the formation of plaque in the coronary arteries. Therefore, managing liver health is <em>cardiovascular</em> management.</p>

 <ul>
 <li><strong>ALT/AST Ratio:</strong> An ALT > AST often signals early fatty liver before it shows on ultrasound.</li>
 <li><strong>GGT:</strong> An elevated GGT is a sensitive marker of oxidative stress and is strongly correlated with cardiac events.</li>
 </ul>

 <h2 id="activity-pillar">Implementing the 'Activity' (A) Pillar for Arterial Health</h2>
 <p>Not all exercise is created equal when it comes to the heart. While the <strong>S.T.E.A.D.Y. Method‚Ñ¢</strong> emphasizes resistance training for glucose tuning, we must also incorporate specific modalities for vascular elasticity.</p>

 <h3>The "Vascular Flush" Protocol</h3>
 <p>Research indicates that <strong>Zone 2 Aerobic Training</strong> (steady-state exercise where you can still hold a conversation) is superior for improving endothelial function and reducing arterial stiffness. In contrast, excessive high-intensity training without adequate recovery can occasionally increase arterial stiffness in stressed PCOS phenotypes.</p>

 <div class="coach-tip">
 <span class="tip-label">The 'A' Pillar Strategy</span>
 <p>For clients with high blood pressure or arterial stiffness, recommend a "10-minute post-meal walk" (The Glucose Buffer) combined with 30 minutes of Zone 2 cardio 3x per week. This specific timing optimizes nitric oxide release when the vessels are under the most "stress" from post-meal glucose spikes.</p>
 </div>

 <h2 id="raas-monitoring">Long-term Monitoring: Lean vs. Adrenal PCOS</h2>
 <p>Cardiovascular risk is not exclusive to the "insulin-resistant" phenotype. We must be vigilant with <strong>Lean PCOS</strong> and <strong>Adrenal PCOS</strong> clients as well.</p>

 <p><strong>Lean PCOS:</strong> These clients often have higher levels of <em>sympathetic nervous system</em> activity (fight or flight). They may have low-normal BMI but "hidden" visceral fat (TOFI - Thin Outside, Fat Inside), which drives inflammation just as aggressively as overt obesity.</p>

 <p><strong>Adrenal PCOS:</strong> These clients may have elevated <em>DHEA-S</em>. Excess adrenal androgens can contribute to a "stiffened" vascular response during stress. For these clients, monitoring <strong>Heart Rate Variability (HRV)</strong> is a key cardiovascular metric to ensure the nervous system isn't driving vascular damage.</p>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is ApoB considered a more accurate marker than LDL-C for a PCOS client with high triglycerides?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">LDL-C only measures the weight of the cholesterol. In PCOS, clients often have many small, dense LDL particles. ApoB measures the actual particle count. A client can have a "normal" weight of cholesterol (LDL-C) but a dangerously high number of particles (ApoB).</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. How does hyperandrogenism (high testosterone) directly affect blood pressure?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Excess androgens impair the endothelium's ability to produce Nitric Oxide (NO). Without sufficient NO, the blood vessels cannot dilate properly, leading to increased vascular resistance and higher blood pressure.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the "Liver-Heart Axis" in the context of PCOS?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It refers to the fact that NAFLD (fatty liver) causes the liver to release pro-inflammatory cytokines into the blood. These cytokines travel to the heart and arteries, where they accelerate plaque formation and increase the risk of cardiovascular events.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which exercise modality is specifically recommended for improving arterial stiffness?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Zone 2 Aerobic Training (steady-state exercise) is particularly effective for improving endothelial function and reducing arterial stiffness (measured by Pulse Wave Velocity).</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Look Beyond the Basics:</strong> Standard lipid panels miss the "Pattern B" small, dense LDL common in PCOS; always prioritize ApoB for true risk assessment.</li>
 <li><strong>The Androgen Factor:</strong> Hyperandrogenism is a vascular toxin that impairs nitric oxide and drives arterial aging.</li>
 <li><strong>Liver Health is Heart Health:</strong> Reversing NAFLD is a non-negotiable step in preventing long-term cardiovascular disease in PCOS clients.</li>
 <li><strong>Phenotype Matters:</strong> Lean PCOS clients are not immune to CVD; they often face risks driven by sympathetic nervous system overactivity and visceral fat.</li>
 <li><strong>Strategic Activity:</strong> Use Zone 2 cardio and post-meal walking to specifically target vascular elasticity and blood pressure regulation.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li data-num="1">Osibogun, O. et al. (2020). "Polycystic Ovary Syndrome and Cardiometabolic Risk: A Systematic Review." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
 <li data-num="2">Cussons, A. J. et al. (2022). "Polycystic Ovary Syndrome: The Role of Androgens in Endothelial Dysfunction." <em>Frontiers in Endocrinology.</em></li>
 <li data-num="3">Vryonidou, A. et al. (2021). "Non-alcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome." <em>Endocrine Connections.</em></li>
 <li data-num="4">Sniderman, A. D. et al. (2023). "Apolipoprotein B vs LDL Cholesterol and Non-HDL Cholesterol as the Primary Marker of Cardiovascular Risk." <em>JAMA Cardiology.</em></li>
 <li data-num="5">Armeni, E. et al. (2022). "Arterial Stiffness in Women with Polycystic Ovary Syndrome: A Meta-analysis." <em>Human Reproduction Update.</em></li>
 <li data-num="6">Mazurek, A. et al. (2021). "The Renin-Angiotensin-Aldosterone System in PCOS: A New Perspective on Hypertension." <em>International Journal of Molecular Sciences.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 this.textContent = answer.style.display === 'block' ? 'Hide Answer' : 'Reveal Answer';
 }
 });
 });
</script>

</body>
</html>